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The Contribution of Symptoms of Posttraumatic Stress Disorder,
Health Anxiety and Intolerance of Uncertainty to Distress in
Me´nie`re Disease
Sarah E. Kirby, PhD, and Lucy Yardley, PhD
Abstract: This study assessed whether symptoms of posttraumatic stress
disorder (PTSD), health anxiety, and intolerance of uncertainty were asso-
ciated with distress in members of the Me´nie`re Society (n  800), and
compared the extent of anxiety, depression, intolerance of uncertainty, and
health anxiety with a healthy control group (n 484). PTSD symptoms were
associated with anxiety, depression, and handicap. Health anxiety was
associated with anxiety and depression. Intolerance of uncertainty was
directly associated with anxiety; its association with depression and handicap
was mediated by PTSD symptoms. The Me´nie`re group reported more
anxiety, depression, and health anxiety than the control group, but were not
more intolerant of uncertainty. More than half of the Me´nie`re group reported
experiencing partial or full PTSD symptoms. As PTSD, health anxiety and
intolerance of uncertainty are modifiable with psychological treatment, we
advise that clinicians should screen patients with Me´nie`re disease who are
particularly distressed.
Key Words: Vertigo, vestibular disease, dizziness, psychological
adjustment, quality of life.
(J Nerv Ment Dis 2009;197: 000–000)
Me´nie`re disease is a chronic, incurable disease that progres-sively damages the parts of the inner ear responsible for
balance and hearing. Symptoms comprise of intermittent, unpredict-
able attacks of severe vertigo (a strong sense of spinning and
unsteadiness, sweating, nausea, and vomiting), tinnitus, a sensation
of pressure or fullness in the ear, and progressive hearing loss that
becomes permanent in 1 or in both the ears. These symptoms have
a negative impact on quality of life (Yardley et al., 2003), and high
levels of distress are often reported among people with Me´nie`re
disease (Best et al., 2006; Cohen et al., 1995). The relationship
between Me´nie`re disease and distress is a complex one, as the
vestibular and autonomic systems are neurologically linked (Bala-
ban and Thayer, 2001; Brandt, 2000; Furman and Jacob, 2001).
Autonomic arousal can be triggered by vestibular disturbance as
well as anxiety arousal, leading to the inclusion of vestibular
disorder as an example in the DSM-IV-TR criterion for anxiety
disorder due to a general medical condition.
The presence of an anxiety disorder can have a negative
impact on quality of life (Cramer et al., 2005), however, few
psychological interventions have been developed to attempt to
reduce distress in people with Me´nie`re disease. Cognitive behavioral
therapy (CBT) has been used successfully to reduce distress in many
chronic disorders, and case studies have suggested that CBT may be
useful for people with Me´nie`re disease (Elwood et al., 1982; Hag-
nebo et al., 1998). Elements of CBT have been incorporated into
physical rehabilitation programs for chronic dizziness and brief
self-help interventions for Me´nie`re disease (Andersson et al., 2006;
Jacob et al., 2001; Johansson et al., 2001; Yardley and Kirby, 2006).
These interventions have achieved reduction in symptoms but have
had only limited effects on anxiety and depression. To develop more
extensive psychological interventions for people with Me´nie`re dis-
ease, we need to understand the modifiable psychological processes
and mechanisms involved.
A systematic review (Kirby and Yardley, 2008) identified
posttraumatic stress disorder (PTSD) and health anxiety as 2 possi-
ble mechanisms that may contribute to distress in Me´nie`re disease,
but their potential role needs to be tested empirically. PTSD is
diagnosed when a traumatic event is experienced with a sense of
fear, helplessness or horror, and results in distress or impairment in
functioning. The addition of “being diagnosed with a life threatening
illness” as a possible traumatic event in the DSM-IV criterion for
PTSD has led to the reporting of PTSD following a range of medical
illnesses and treatments (Kangas et al., 2002; Tedstone and Tarrier,
2003). In Me´nie`re disease, attacks of vertigo have been described as
terrifying, resulting in feelings of helplessness and powerlessness
(Yardley, 1997). The first attack in particular may be perceived as
life threatening, as people do not know what is happening to them
(Pollak et al., 2003; Yardley, 1997). Symptoms of PTSD such as
avoidance behavior and increased levels of arousal have been
reported among people with vestibular disorders (Cohen et al., 1995;
Jacob et al., 2002; Yardley et al., 1998). Vertigo attacks are recur-
rent, and PTSD can result from cumulative events (Alonzo, 2000).
Even when people do not fulfil the full DSM diagnostic criteria, they
may still suffer from some PTSD symptoms which need treatment
(Mylle and Maes, 2004). It seems likely that some people with
Me´nie`re disease may develop some or all of the features of PTSD.
Health anxiety was defined by Fava et al., (1995) as a generic
worry about illness and preoccupation with somatic sensations.
Furer et al. (2001) have suggested that people have an increased risk
of developing health anxiety if they have a condition that is chronic,
intermittent, degenerative, involves uncertainty, or has no clearly
recognized cause. As all these risk factors are features of Me´nie`re
disease, people with Me´nie`re disease may be vulnerable to devel-
oping health anxiety. Indeed, a recent study (Best et al., 2006) found
that people with Me´nie`re disease had higher rates of anxiety,
depression, and somatoform disorders than those with other types of
vestibular disorder (such as BPPV and vestibular neuritis).
In addition to PTSD and health anxiety, this study also
investigates the possible contribution of a third mechanism to
distress, intolerance of uncertainty. Intolerance of uncertainty is a
cognitive bias whereby a person will evaluate uncertain situations as
negative and stressful, and believe that uncertain situations should
be avoided (Dugas et al., 2005). Dislike of the uncertainty of attacks
among people who experience chronic vertigo is often noted anec-
dotally (Yardley, 1997). In Me´nie`re disease, attacks are particularly
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unpredictable, varying greatly in severity and duration, with periods
of remission between attacks ranging from days to years. The first
study to investigate the impact of intolerance of uncertainty on distress
in people with Me´nie`re disease found that intolerance of uncertainty
was indeed strongly associated with anxiety among people with Me´-
nie`re disease (Kirby and Yardley, 2009). It has been suggested that
intolerance of uncertainty may be an underpinning feature of anxiety
disorders in general (Holaway et al., 2006), with people with anxiety
disorders having higher levels of intolerance of uncertainty than non-
clinical controls (Ladouceur et al., 1999). The purpose for including
intolerance of uncertainty in this study, therefore, was to see whether
the findings of the previous study could be replicated, and to assess
whether intolerance of uncertainty contributes independently to distress
in people with Me´nie`re disease when included with health anxiety and
PTSD. Like PTSD and health anxiety, intolerance of uncertainty has
been treated successfully in other populations using psychological
interventions (Dugas and Ladouceur, 2000; Jones, 2002; National
Institute for Clinical Excellence, 2005).
The primary aim of this study was to assess whether PTSD,
health anxiety, and intolerance of uncertainty are associated with
distress (i.e., anxiety, depression, and handicap) in people with
Me´nie`re disease, after controlling for demographic and illness char-
acteristics. A secondary aim was to compare the extent of anxiety,
depression, intolerance of uncertainty, and health anxiety in people
with Me´nie`re disease group and a healthy control group.
METHOD
Participant Recruitment and Procedure
Participants were recruited by sending questionnaire packs to
1400 randomly selected members of the Me´nie`re Society, inviting
them to participate. Members were asked to return the pack if they
did not want to take part in the study. Up to 2 reminders were sent
to nonresponders at 1 month intervals. To be eligible to participate,
participants were required to indicate that they had received a
diagnosis of Me´nie`re disease from their doctor. Control participants
were recruited by including a control questionnaire in the initial
pack sent to the members, to be completed by a willing friend or
relative without Me´nie`re disease or severe dizziness. The study was
approved by the Ethical Committee of the School of Psychology,
University of Southampton.
Measures
Single items were used to assess age, gender, length of time
since symptoms began (illness duration), and length of time since
last attack (illness recency). Vertigo and somatic anxiety were
assessed using the long version of the Vertigo Symptom Scale
(Yardley et al., 1992). Tinnitus and fullness in the ear were assessed
using the Tinnitus Severity Index and the Aural Pressure Index
(Cass, 1999; Stahle et al., 1981). Hearing disability was assessed
using the Hearing Disability Questionnaire (Lutman et al., 1987).
The English version of the Intolerance of Uncertainty Scale
(Buhr and Dugas, 2002) was used to assess how participants might
interpret and respond to uncertainty. Health anxiety was measured
using the short-form Health Anxiety Inventory (Salkovskis et al.,
2002). Although the short-form Health Anxiety Inventory is suitable
for use with people who have a physical illness, minor amendments
were made to the items that refer to having a serious disease, to
specify a serious disease other than Me´nie`re disease. To assess
clinical levels of health anxiety, scores were recoded to show no
health anxiety if scores were in the 0 to 14 range, high health anxiety
if scores were in the 15 to 17 range, and hypochondriasis if scores
were 18 or more (Rode et al., 2006).
PTSD was measured using the PTSD checklist (PCL)
(Weathers et al., 1993), a 17-item scale that follows the DSM-IV
criteria for PTSD. For the purposes of this study, the introductory
text and questions were worded to specifically refer to the extent that
respondents had experienced symptoms in the past month in relation
to a severe Me´nie`re attack. Two different methods were used to
determine clinical levels of PTSD. The first method was proposed by
Blanchard et al. (1996) who recommended that a simple score of 44
or more is used to identify PTSD. The second method was proposed
by the National Center for PTSD who recommended symptomatic
clusters are required in addition to a total score of 44 or more
(Weathers et al., 1993). The symptomatic cluster requirements for
clinical levels of criterion B (re-experiencing) are that at least 1 item
on that subscale must be scored 3 or above. The requirements for
clinical levels of criterion C (avoidance/numbing) are that at least 3
items on that subscale must be scored 3 or above. To meet the
requirement for clinical levels of criterion D (arousal), at least 2
items on that subscale must be scored 3 or above.
Depression and anxiety were measured using the Hospital
Anxiety and Depression Scale (Zigmond and Snaith, 1983). To
determine clinical levels, anxiety and depression were coded as non
clinical if scores were in the 0 to 7 range, possibly clinical if scores
were in the 8 to 10 range, and clinical if scores were 11 or more
(Zigmond and Snaith, 1983). Handicap resulting from dizziness was
measured using the total score of the Dizziness Handicap Inventory
(Jacobson and Newman, 1990).
Statistical Analysis
Hierarchical regression was used to assess the effects of the
psychological variables on distress, after controlling for demo-
graphic and illness characteristics. Age and gender were entered into
the first step; illness characteristics were entered into the second
step; and PTSD, health anxiety, and intolerance of uncertainty were
entered on the final step. These regressions were carried out to
identify variables associated with anxiety, depression, and handicap.
Post hoc regression analyses were carried out to test whether PTSD
symptoms mediated the relationship of intolerance of uncertainty to
depression and handicap (Baron and Kenny, 1986). To test whether
these reductions in effect were significant, the Aroian version of the
Sobel test was used (Baron and Kenny, 1986).
MANOVA was used to compare the extent of anxiety, de-
pression, intolerance of uncertainty, and health anxiety in people
with Me´nie`re disease and the healthy control group. Although
preliminary t-tests found age and gender differences between the
groups, MANCOVA could not be used to control for age and gender
due to violation of the homogeneity of regression assumption.
Therefore, age was dichotomized (60 vs. 60 years) and included
with gender and group (Me´nie`re disease vs. control) as fixed factors
to test for any interactions between these variables. Follow-up
ANOVAs were carried out to identify which dependent variables the
Me´nie`re disease and control group differed on.
RESULTS
Of the 1400 members of the Me´nie`re Society who were invited
to take part in the study, data from 800 (57.1%) were included in the
final analyses (mentioned in Fig. 1 for reasons for nonparticipation or
exclusion). The age range was 25 to 90 years, with 295 (36.9%) men
and 505 (63.1%) women. In the control group, data from 484 (34.6%)
were included in the analyses. The control group comprised 216
(44.6%) men and 268 (55.4%) women, and the age range was 18 to 93
years. The means and standard deviations for all variables measured in
both groups are presented in Table 1.
Variables Associated With Distress
The bivariate correlations between demographic and illness
characteristics, psychological variables, and the 3 measures of dis-
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tress (anxiety, depression, and handicap) are shown in Table 2. With
the exception of illness duration and age (for depression and hand-
icap), all variables were significantly correlated with anxiety, de-
pression, and handicap. Large effect sizes were observed for the
presence of PTSD and health anxiety symptoms, intolerance of
uncertainty, and reporting more somatic anxiety and vertigo.
TABLE 1. Means, Standard Deviations (SD), and Effect Size
(Cohen d) Comparing the Ménière and Control Groups
Ménière
Group
(n  800)
Control
Group
(n  484) Effect
Size
dMean SD Mean SD
Demographic characteristics
Age 60.54 12.54 55.57 14.44 0.37
Illness characteristics
Illness duration (mo) 168.86 122.78 — — —
Illness recency (d) 512.94 1037.40 — — —
Vertigo 19.39 15.53 — — —
Somatic anxiety 18.91 12.75 — — —
Tinnitus 3.80 1.54 — — —
Fullness in the ear 3.24 1.55 — — —
Hearing disability 13.87 7.46 — — —
Psychological variables
Intolerance of uncertainty 51.33 20.28 50.29 16.62 0.06
Health anxiety 11.01 6.14 8.56 5.10 0.43
PTSD 31.62 11.40 — — —
Distress
Anxiety 7.68 4.68 5.88 3.73 0.43
Depression 5.49 4.02 3.12 2.72 0.69
Handicap 47.20 24.44 — — —
FIGURE 1. ●●●.
TABLE 2. Bivariate Correlations (Pearson r) Between
Anxiety, Depression, and Handicap, and Demographic and
Illness Characteristics and Psychological Variables
Anxiety
(r)
Depression
(r)
Handicap
(r)
Demographic characteristics
Age 0.15* .02 .04
Gender 0.20* 0.07** 0.22*
Illness characteristics
Illness duration 0.01 0.00 0.05
Illness recency 0.16* 0.19* 0.28*
Vertigo 0.40* 0.46* 0.58*
Somatic anxiety 0.59* 0.56* 0.65*
Tinnitus 0.17* 0.17* 0.17*
Fullness in the ear 0.36* 0.36* 0.43*
Hearing disability 0.17* 0.27* 0.32*
Psychological variables
Intolerance of uncertainty 0.66* 0.54* 0.47*
Health anxiety 0.61* 0.53* 0.45*
PTSD 0.73* 0.73* 0.65*
Distress
Anxiety — 0.68* 0.62*
Depression — 0.71*
*p  0.001, **p  0.05.
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Beta coefficients for the final regression models for anxiety,
depression, and handicap are shown in Table 3. For anxiety, 66% of
the variance was accounted for by the final regression equation
(F(12,787)  124.48, p  0.001). Illness characteristics accounted
for 31% of this variance (F R2 change (7790)  56.07, p  0.001),
and the psychological variables accounted for a further 28% (F R2
change (3787)  215.485, p  0.001). In the final model, the
variables that contributed most to anxiety were the presence of
PTSD symptoms, and intolerance of uncertainty. Experiencing
symptoms of somatic anxiety and reporting more health anxiety
made the next largest contributions to anxiety.
A total of 59% of the variance in depression was accounted
for by the final regression equation (F(12,787)  95.28, p  0.001).
Illness characteristics accounted for 36% of the variance (F R2
change (7790)  64.79, p  0.001), and psychological variables
accounted for a further 22% (F R2 change (3787)  144.34, p 
0.001). The variables that contributed most to the final model of
depression were the presence of PTSD symptoms, health anxiety,
and vertigo symptoms.
The final regression equation accounted for 63% of the
variance for handicap (F(12,787)  110.43, p 0.001). Most of the
variance (49%) was accounted for by illness characteristics (F R2
change (7790)  121.85, p  0.001), with only a further 9% of the
variance being accounted for by the psychological variables (F R2
change (3787)  60.01, p  0.001). In the final model, PTSD
symptoms contributed most to handicap, followed by symptoms of
vertigo, somatic anxiety, and hearing disability.
PTSD almost fully mediated the relationship of intolerance of
uncertainty with handicap and depression. The inclusion of PTSD
reduced the association between intolerance of uncertainty and
depression from a standardized Beta coefficient of 0.54 to 0.08,
which was only just still significant (p  0.022). For handicap, the
inclusion of PTSD as a mediator reduced the strength of association
with intolerance of uncertainty from a standardized Beta coefficient
of 0.48 to 0.05, which was no longer significant (p  0.138). The
standardized Beta coefficient for the relationship between intoler-
ance of uncertainty and PTSD was 0.68 (p  0.001). The results
suggest that PTSD significantly mediated the effect of intolerance of
uncertainty on depression (Aroian  15.61, p  0.001) and hand-
icap (Aroian  14.12, p  0.001).
Comparison Between Me´nie`re Disease and Control
Groups
The secondary aim of this study was to compare the extent of
anxiety, depression, intolerance of uncertainty, and health anxiety in
people with Me´nie`re disease group and a healthy control group (men-
tioned in Table 1 for means). Significant differences were found
between the Me´nie`re disease and control group (Wilks’  0.88, F(4,
1273)  43.03, p  0.001, p
2  0.12). Participants in the Me´nie`re
disease group were significantly more anxious and depressed than
controls (anxiety: F(1, 1276)  47.20, p  0.001, p
2  0.04, depres-
sion: F(1, 1276) 117.39, p 0.001, p
2 0.08). The Me´nie`re disease
group also reported more health anxiety (F(1, 1276)  53.73,
p  0.001, p
2  0.04). No difference was found between the Me´nie`re
and control group for intolerance of uncertainty. No interaction effects
were found between age, gender, and group.
The proportion of each group with clinical levels of anxiety,
depression, health anxiety, and PTSD is shown in Table 4. The
proportion of the Me´nie`re disease group with clinical levels of distress
was significantly higher than the control group for anxiety (2 2, N 
800  253.47, p  0.001), depression (2 2, N  800  859.53,
p  0.001), and health anxiety (2 2, N  800  145.76, p 
0.001). Proportions ranged from 1.8 to 9.8 times higher in the
Me´nie`re group than the control group.
A total of 16.4% of the Me´nie`re group met the criteria for
PTSD of scores of 44 or more on the PCL, whereas 12.1% met the
criteria of the National Center for PTSD. The presence of only one
of the B, C, or D symptomatic clusters in response to a traumatic
TABLE 3. Beta Coefficients for the Final Regression Models
for Anxiety, Depression, and Handicap, Controlling for
Demographic Variables and Symptom Severity
Anxiety
()
Depression
()
Handicap
()
Demographic characteristics
Age 0.04 0.10* 0.07**
Gender 0.09* 0.02 0.11*
Illness characteristics
Illness duration 0.02 0.03 0.04
Illness recency 0.02 0.00 0.08*
Vertigo 0.01 0.14* 0.24*
Somatic anxiety 0.18* 0.11** 0.20*
Tinnitus 0.01 0.00 0.03
Fullness in the ear 0.02 0.02 0.07**
Hearing disability 0.00 0.07** 0.14*
Psychological variables
Intolerance of uncertainty 0.24* 0.06*** 0.07***
Health anxiety 0.17* 0.15* 0.07***
PTSD 0.35* 0.45* 0.27*
*p  0.001, **p  0.01, ***p  0.05.
TABLE 4. Clinical Groupings of Ménière’s and Control
Groups for Anxiety, Depression, Health Anxiety, and PTSD
Ménière’s
Group
Control
Group
N
% of
Ménière’s
Group N
% of
Control
Group
Anxiety (HADS)
Non-clinical (7 points) 418 52.3 356 73.6
Possible clinical (8–10 points) 159 19.9 73 15.1
Clinical (11 points) 223 27.9 55 11.4
Depression (HADS)
Non-clinical (7 points) 571 71.4 444 91.7
Possible clinical (8–10 points) 135 16.9 34 7.0
Clinical (11 points) 94 11.8 6 1.2
Health anxiety (SHAI)
No. health anxiety (14 points) 596 74.5 427 88.2
High health anxiety (15–17 points) 96 12.0 28 5.8
Hypochondriasis (18 points) 108 13.5 29 6.0
PTSD (PCL)
Re-experiencing 244 30.0
Avoidance/numbing 231 28.9
Arousal 351 43.9
0/3 clusters 347 43.4
1/3 clusters 197 24.6
2/3 clusters 139 17.4
3 clusters 117 14.6
Score 44 131 16.4
3 clusters and score 44 97 12.1
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event that is causing distress can be taken as an indication of partial
PTSD (Mylle and Maes, 2004). Using this criterion, 42% of partic-
ipants reached the threshold for 1 or 2, but not all 3, of the
symptomatic clusters.
DISCUSSION
Our findings suggest that the modifiable psychological mecha-
nisms of PTSD, health anxiety, and intolerance of uncertainty do
contribute to distress in this group of members of the Me´nie`re Society.
The presence and contribution of PTSD symptoms to distress is par-
ticularly noteworthy, as the proportion of this sample of people with
Me´nie`re disease who met the criteria for PTSD is much higher than the
general population level of 1.5% to 1.8% (National Institute for
Clinical Excellence, 2005). This proportion is also higher than those
who have had a stroke (9.8%), and is comparable to people who
have had a myocardial infarction (0%–16%) or cardiac surgery
(10.8%–18%; Tedstone and Tarrier, 2003). According to the criteria
for partial PTSD proposed by Mylle and Maes (2004), over half of
the sample met criteria for partial or full PTSD.
As was found in this study, the occurrence of PTSD with
anxiety and/or depression is common (National Institute for Clinical
Excellence, 2005). It has been suggested that PTSD often remains
unrecognized when the primary presenting problem is depression or
an anxiety disorder (Zimmerman and Mattia, 1999). This may
contribute to why PTSD has not been explored as a possible
mechanism for distress in people with Me´nie`re disease before. The
comorbidity of PTSD with anxiety and/or depression should not
complicate treatment of either condition, as the effective treatment
of PTSD has been found to improve untreated symptoms of anxiety
and depression (National Institute for Clinical Excellence, 2005). It
may therefore be beneficial for clinicians to screen patients who
seem particularly distressed and poorly adjusted to having Me´nie`re
disease for the possible presence of PTSD.
The levels of health anxiety reported by participants with
Me´nie`re disease were significantly higher than those of the control
group in this study, and appear to be similar to those of medical
patients who were attending a general practice clinic, gastroenter-
ology clinic, or an MRI scan (Salkovskis et al., 2002). The levels of
health anxiety reported by people with Me´nie`re disease in this study,
however, appear to be lower than those reported by people with
panic disorder, and much lower than people with hypochondriasis
(Salkovskis et al., 2002).
The level of intolerance of uncertainty in the Me´nie`re group
appeared to be comparable to the scores of non-anxious people in
other research (Buhr and Dugas, 2002; Buhr and Dugas, 2006), and
lower than people with anxiety disorders (Holaway et al., 2006;
Ladouceur et al., 1999). This suggests that while high levels of
intolerance of uncertainty contribute to distress in the Me´nie`re
disease group, the distribution of intolerance of uncertainty within
the Me´nie`re group as a whole was comparable to normal popula-
tions. PTSD and health anxiety were both directly associated with all
3 types of distress. Intolerance of uncertainty, however, was asso-
ciated with the different types of distress in different ways. A high
level of intolerance of uncertainty was directly and quite strongly
associated with anxiety, but its effect on depression and handicap
was almost fully mediated by PTSD symptoms.
The main strengths of our study were that it is the first to
assess the presence and role of PTSD and health anxiety in a large
sample of people with Me´nie`re disease. The study is limited,
however, by a cross-sectional design using a self-selected sample
from a self-help group. It is possible that elevated levels of distress
may have been a motivating factor in participants’ decision to join
the self-help group, and so these results cannot be generalized to all
people with Me´nie`re disease without replication in a non self-help
group sample. Another limitation of the study is that it was beyond
the scope of the study to clinically confirm the diagnosis of Me´nie`re
disease in participants, although all participants reported symptoms
of vertigo, tinnitus, aural fullness, and hearing disability, and re-
ported that they had been told by a doctor that they have Me´nie`re
disease. The recruitment of participants’ friends and relatives (with-
out Me´nie`re disease or severe dizziness) as a control group was also
a limitation of the study. As this group was a convenience sample
and not randomly selected, we cannot assume that the control group
is representative of the general population.
The study was also limited by the use of self report measures,
although the measure used to assess PTSD in this study (the PCL) has
been reported to have good diagnostic efficiency (Blanchard et al.,
1996). PTSD, however, has not previously been studied in people with
Me´nie`re disease; given the strong association of PTSD with distress
found in this study, future research should seek to replicate this finding
using clinical interviews. It should also be noted that this study only
measured PTSD symptoms experienced over the past month. Given the
fluctuating nature of Me´nie`re symptoms, it would be interesting if
future studies could assess the lifetime prevalence of PTSD symptoms
in people with Me´nie`re disease.
CONCLUSIONS
Our study has shown that PTSD, health anxiety, and intoler-
ance of uncertainty may be relevant mechanisms for understanding
distress among people with Me´nie`re disease. As previous research
with other populations has shown that these mechanisms are mod-
ifiable with psychological treatment, our study has important impli-
cations for the psychological treatment of distress in people with
Me´nie`re disease.
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